On ECHEMI
Home > Drugs > Macitentan Registered Holders
Macitentan structure

Macitentan structure

Macitentan

Macitentan is an orally active, non-peptide endothelin receptor antagonist for the treatment of idiopathic pulmonary fibrosis and pulmonary arterial hypertension.

Find 24 Related Holders

SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD
United States United States

API Registration Country

API Active
HONOUR LAB LTD
United States United States

API Registration Country

API Active
LAURUS LABS LTD
United States United States

API Registration Country

API Active
RAKS PHARMA PVT LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
ZYDUS LIFESCIENCES LTD
United States United States

API Registration Country

API Active
TAPI NL B.V.
France France

API Registration Country

API Active
  • Founded in:

    2025-02-04 00:00:00
  • Country:

    France France
  • Address:

    55 Piet Heinkade 1019GM Amsterdam PAYS-BAS
  • Email:

Biobetta Pharmaceuticals (Shanghai) Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2016-07-15
  • Country:

    China China
  • Address:

    Room C- 22, Floor 4, Building 1, 198 Huashen Road, China (Shanghai) Pilot Free Trade Zone
  • Tax NO.:

    91310115MA1K3EF230
  • Registered Funds:

    $1 million
  • Website:

  • Email:

Recommended Suppliers of Macitentan
View 69 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.